Molecular Partners AG
MOLN
$3.88
-$0.07-1.77%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -10.86% | -4.79% | -17.11% | -10.32% | -17.80% |
| Gross Profit | 10.86% | 4.79% | 11.57% | -1.74% | -2.01% |
| SG&A Expenses | 6.57% | -7.83% | -11.61% | -1.39% | -8.61% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.30% | -5.89% | -15.53% | -8.06% | -15.58% |
| Operating Income | 6.30% | 5.89% | 11.58% | -0.87% | 1.00% |
| Income Before Tax | 11.83% | -23.77% | 21.98% | -48.26% | -44.04% |
| Income Tax Expenses | -- | 117.39% | -- | -- | -- |
| Earnings from Continuing Operations | 11.82% | -23.79% | 21.98% | -48.26% | -44.03% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.82% | -23.79% | 21.98% | -48.26% | -44.03% |
| EBIT | 6.30% | 5.89% | 11.58% | -0.87% | 1.00% |
| EBITDA | 6.60% | 5.99% | 11.92% | -0.88% | 0.59% |
| EPS Basic | 13.30% | -22.03% | 30.77% | -31.58% | -28.37% |
| Normalized Basic EPS | 13.28% | -22.43% | 31.45% | -14.71% | -28.38% |
| EPS Diluted | 13.30% | -21.30% | 30.77% | -31.58% | -28.37% |
| Normalized Diluted EPS | 13.28% | -22.43% | 31.45% | -14.71% | -28.38% |
| Average Basic Shares Outstanding | 1.70% | 1.44% | 12.67% | 12.69% | 12.19% |
| Average Diluted Shares Outstanding | 1.70% | 1.44% | 12.67% | 12.69% | 12.19% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |